Nutrition and Food Research Center (NuFo)

  

  

  

1 of 2

  

  

  

---

• Alanne, SoiliKoivuniemi, Ella
• Bekele, HelenKoskimäki, Sanna
• Haataja, KiraLähde, Hanna
• Hieta, JaninaLaikola, Sini
• Hopia, AnuLehtinen, Maarit
• Houttu, NooraLepistö, Leo
• Houttu, VeeraLogren, Nora
• Jakonen, MitjaMattila, Saila
• Jylhä, Aino
• Kaya Kacar, HüsnaMokkala, Kati
• Kerttula, Anni

  

  

  

87 of 110

  

  

  

---

• Scientific Opinion on the substantiation of health claims related to partially hydrolysed guar gum and increase in satiety (ID 790), maintenance or achievement of a normal body weight (ID 790), maintenance of normal blood concentrations of triglycerides (ID 793, 816), maintenance of normal blood cholesterol concentrations (ID 793, 816), reduction of post-prandial glycaemic responses (ID 789, 2932) and maintenance of normal blood glucose concentrations (ID 792) pursuant to Article 13(1) of Regulation (EC) No 1924/2006Scientific Opinion on the substantiation of health claims related to peanuts, peanut oil and peanut butter manufactured exclusively from roasted peanuts, and maintenance of normal blood LDL cholesterol concentrations (ID 1284) pursuant to Article 13(1) of Regulation (EC) No 1924/2006  (2010)
• Scientific Opinion on the substantiation of health claims related to partially hydrolysed guar gum (PHGG) and decreasing potentially pathogenic gastro-intestinal microorganisms (ID 788), changes in short chain fatty acid (SCFA) production and/or pH in the gastro-intestinal tract (ID 787, 813), changes in bowel function (ID 813, 853, 1902, 1903, 1904, 2929, 2930, 2931), and reduction of gastro-intestinal discomfort (ID 813, 1902, 1903, 1904, 2929, 2930, 2931) pursuant to Article 13(1) of Regulation (EC) No 1924/2006Scientific Opinion on the substantiation of health claims related to pectins and reduction of post-prandial glycaemic responses (ID 786), maintenance of normal blood cholesterol concentrations (ID 818) and increase in satiety leading to a reduction in energy intake (ID 4692) pursuant to Article 13(1) of Regulation (EC) No 1924/2006  (2011)
•   (2011)
• Scientific Opinion on the substantiation of health claims related to phosphorus and reduction of tiredness and fatigue (ID 323) pursuant to Article 13(1) of Regulation (EC) No 1924/2006  (2010)
• Scientific Opinion on the substantiation of health claims related to phaseolamine and reduction in body weight (ID 1701) pursuant to Article 13(1) of Regulation (EC) No 1924/2006Scientific Opinion on the substantiation of health claims related to plant sterols and plant stanols and maintenance of normal blood cholesterol concentrations (ID 549, 550, 567, 713, 1234, 1235, 1466, 1634, 1984, 2909, 3140), and maintenance of normal prostate size and normal urination (ID 714, 1467, 1635) pursuant to Article 13(1) of Regulation (EC) No 1924/2006  (2011)
• Scientific Opinion on the substantiation of health claims related to phosphatidyl serine (ID 552, 711, 734, 1632, 1927) pursuant to Article 13(1) of Regulation (EC) No 1924/2006Scientific Opinion on the substantiation of health claims related to policosanols from sugar cane wax and maintenance of normal blood LDL-cholesterol concentrations (ID 1747, 1748, 1864, 1951, 1954, 4693) and maintenance of normal blood HDL-cholesterol concentrations (ID 1747, 1748, 1864, 1951, 1954, 4693) pursuant to Article 13(1) of Regulation (EC) No 1924/2006  (2010)
•   (2011)
•   (2010)
•   (2011)
• Scientific Opinion on the substantiation of health claims related to polydextrose and changes in bowel function (ID 784), changes in short chain fatty acid (SCFA) production and/or pH in the gastro-intestinal tract (ID 784), decreasing potentially pathogenic gastro-intestinal microorganisms (ID 785) and reduction of gastro-intestinal discomfort (ID 784) pursuant to Article 13(1) of Regulation (EC) No 1924/20062011